Cipla Limited, a leader in respiratory care, has launched India's pioneering integrated lung diagnostics and wellness center, the Breathefree Lung Wellness Center, in Lajpat Nagar, New Delhi. This initiative aims to redefine respiratory care by making advanced, world-class standardized lung diagnostics accessible and affordable for both doctors and patients nationwide.

Designed as a one-stop solution for comprehensive lung health diagnostics, the center draws on Cipla’s extensive expertise in respiratory diseases. It combines cutting-edge technology, globally recognized diagnostic protocols, and a team of highly trained technical professionals to ensure precision testing for early and accurate detection of respiratory diseases.

The facility provides a comprehensive suite of over 60 tests, encompassing lung physiology, microbiology, immunology, blood chemistry, and radiology. This extensive testing framework allows for a thorough evaluation of the lungs for patients suspected of or already diagnosed with various conditions, from common ailments like Asthma and COPD to complex interstitial lung diseases (ILD).

Available tests, conducted by expert technicians to eliminate inconsistencies, include Spirometry, Oscillometry, FeNO, DLCO, Body Plethysmography, CPET, X-Ray, CT scans, and sleep studies. Beyond diagnostics, the center supports patient rehabilitation through pulmonary nutrition and rehabilitation services, as well as smoking cessation counseling.

The center is currently open and accepting patients via referrals from clinicians, offering the highest standards in respiratory diagnostics and care.

Commenting on this milestone, Achin Gupta, Global Chief Operating Officer, Cipla Limited, said, "Cipla has long been a pioneer in respiratory care, and with the launch of the first Breathefree Lung Wellness Center, we are addressing a critical gap in the diagnostic landscape. By expanding our presence across the care continuum, we are aiming to transform lung health diagnostics in India by making high-quality, standardised lung diagnostics accessible to healthcare professionals and patients, ultimately improving respiratory health outcomes."

Dr. Jaideep Gogtay, Global Chief Medical Officer, Cipla Limited, added, "India is estimated to have over 90 million people with chronic respiratory diseases. Early and accurate diagnosis is crucial for physicians to initiate appropriate treatment for their patients, reduce the risk for hospitalization and improve the quality of life. Cipla has always recognised the need to address this burden, and the launch of this center is a natural extension of our lung leadership efforts. Through this initiative, we aim to transform lung health diagnostics in India by strengthening the foundation of respiratory care."

Beyond being a holistic lung wellness center, it aims to become an extensive training center for health care professionals on the latest diagnostic methodologies and get them certified. There will also be opportunities for conducting research to advance respiratory science.